Literature DB >> 28860345

Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients.

Nitin Jain1, Xinyan Lu2, Naval Daver1, Beenu Thakral2, Sa A Wang2, Sergej Konoplev2, Keyur Patel2, Rashmi Kanagal-Shamanna2, Marcus Valentine3, Guilin Tang2, Naveen Pemmaraju1, Jeffrey Jorgensen2, Partow Kebriaei4, Cesar A Nunez5, William Wierda1, Elias Jabbour1, Kathryn G Roberts3, Charles G Mullighan3, Hagop Kantarjian1, Marina Konopleva6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28860345      PMCID： PMC5709127          DOI： 10.3324/haematol.2016.161000

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  18 in total

1.  A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011).

Authors:  Mignon L Loh; Sarah K Tasian; Karen R Rabin; Patrick Brown; Daniel Magoon; Joel M Reid; Xuejun Chen; Charlotte H Ahern; Brenda J Weigel; Susan M Blaney
Journal:  Pediatr Blood Cancer       Date:  2015-05-13       Impact factor: 3.167

2.  IGH@ translocations co-exist with other primary rearrangements in B-cell precursor acute lymphoblastic leukemia.

Authors:  Sally J Jeffries; Lisa Jones; Christine J Harrison; Lisa J Russell
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

3.  High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

Authors:  Kathryn G Roberts; Zhaohui Gu; Debbie Payne-Turner; Kelly McCastlain; Richard C Harvey; I-Ming Chen; Deqing Pei; Ilaria Iacobucci; Marcus Valentine; Stanley B Pounds; Lei Shi; Yongjin Li; Jinghui Zhang; Cheng Cheng; Alessandro Rambaldi; Manuela Tosi; Orietta Spinelli; Jerald P Radich; Mark D Minden; Jacob M Rowe; Selina Luger; Mark R Litzow; Martin S Tallman; Peter H Wiernik; Ravi Bhatia; Ibrahim Aldoss; Jessica Kohlschmidt; Krzysztof Mrózek; Guido Marcucci; Clara D Bloomfield; Wendy Stock; Stephen Kornblau; Hagop M Kantarjian; Marina Konopleva; Elisabeth Paietta; Cheryl L Willman; Charles G Mullighan
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

4.  Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.

Authors:  Sarah K Tasian; Michelle Y Doral; Michael J Borowitz; Brent L Wood; I-Ming Chen; Richard C Harvey; Julie M Gastier-Foster; Cheryl L Willman; Stephen P Hunger; Charles G Mullighan; Mignon L Loh
Journal:  Blood       Date:  2012-06-08       Impact factor: 22.113

5.  Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

Authors:  Richard C Harvey; Charles G Mullighan; Xuefei Wang; Kevin K Dobbin; George S Davidson; Edward J Bedrick; I-Ming Chen; Susan R Atlas; Huining Kang; Kerem Ar; Carla S Wilson; Walker Wharton; Maurice Murphy; Meenakshi Devidas; Andrew J Carroll; Michael J Borowitz; W Paul Bowman; James R Downing; Mary Relling; Jun Yang; Deepa Bhojwani; William L Carroll; Bruce Camitta; Gregory H Reaman; Malcolm Smith; Stephen P Hunger; Cheryl L Willman
Journal:  Blood       Date:  2010-08-10       Impact factor: 22.113

6.  Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.

Authors:  Richard C Harvey; Charles G Mullighan; I-Ming Chen; Walker Wharton; Fady M Mikhail; Andrew J Carroll; Huining Kang; Wei Liu; Kevin K Dobbin; Malcolm A Smith; William L Carroll; Meenakshi Devidas; W Paul Bowman; Bruce M Camitta; Gregory H Reaman; Stephen P Hunger; James R Downing; Cheryl L Willman
Journal:  Blood       Date:  2010-02-04       Impact factor: 22.113

Review 7.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

8.  A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.

Authors:  Monique L Den Boer; Marjon van Slegtenhorst; Renée X De Menezes; Meyling H Cheok; Jessica G C A M Buijs-Gladdines; Susan T C J M Peters; Laura J C M Van Zutven; H Berna Beverloo; Peter J Van der Spek; Gaby Escherich; Martin A Horstmann; Gritta E Janka-Schaub; Willem A Kamps; William E Evans; Rob Pieters
Journal:  Lancet Oncol       Date:  2009-01-08       Impact factor: 41.316

9.  Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.

Authors:  Claire J Schwab; Lucy Chilton; Heather Morrison; Lisa Jones; Halima Al-Shehhi; Amy Erhorn; Lisa J Russell; Anthony V Moorman; Christine J Harrison
Journal:  Haematologica       Date:  2013-03-18       Impact factor: 9.941

10.  IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome.

Authors:  Lisa J Russell; Amir Enshaei; Lisa Jones; Amy Erhorn; Dino Masic; Helen Bentley; Karl S Laczko; Adele K Fielding; Anthony H Goldstone; Nicholas Goulden; Christopher D Mitchell; Rachel Wade; Ajay Vora; Anthony V Moorman; Christine J Harrison
Journal:  J Clin Oncol       Date:  2014-04-07       Impact factor: 44.544
View more
  5 in total

1.  Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.

Authors:  Harpreet Virk; Sonia Rana; Praveen Sharma; Parveen Lata Bose; Diksha Dev Yadav; Man Updesh Singh Sachdeva; Neelam Varma; Amita Trehan; Deepesh Lad; Alka Rani Khadwal; Pankaj Malhotra; Sreejesh Sreedharanunni
Journal:  Ann Hematol       Date:  2021-06-22       Impact factor: 3.673

2.  CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways.

Authors:  Dafné Moreno Lorenzana; María Del Rocío Juárez Velázquez; Adriana Reyes León; Daniel Martínez Anaya; Adrián Hernández Monterde; Consuelo Salas Labadía; María Del Pilar Navarrete Meneses; Marta Zapata Tarrés; Luis Juárez Villegas; Berenice Jarquín Ramírez; Rocío Cárdenas Cardós; Martha Herrera Almanza; Rogelio Paredes Aguilera; Patricia Pérez Vera
Journal:  J Pathol Clin Res       Date:  2021-04-23

3.  Characterization of Philadelphia-like Pre-B Acute Lymphoblastic Leukemia: Experiences in Mexican Pediatric Patients.

Authors:  Daniel Martínez-Anaya; Dafné Moreno-Lorenzana; Adriana Reyes-León; Ulises Juárez-Figueroa; Michael Dean; María Montserrat Aguilar-Hernández; Netzi Rivera-Sánchez; Jessica García-Islas; Victoria Vieyra-Fuentes; Marta Zapata-Tarrés; Luis Juárez-Villegas; Rogelio Paredes-Aguilera; Lourdes Vega-Vega; Roberto Rivera-Luna; María Del Rocío Juárez-Velázquez; Patricia Pérez-Vera
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

4.  [The expression of CRLF2 in adult Ph negative acute B lymphocytic leukemia and its prognostic significance].

Authors:  H Chen; X J Wang; S Liu; F F Yuan; H Ai; L Chen; R H Mi; Y Y Xiong; M J Li; R H Fan; Q S Yin; X D Wei
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-10-14

Review 5.  New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia.

Authors:  Jan Starý; Jan Zuna; Marketa Zaliova
Journal:  F1000Res       Date:  2018-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.